INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 122 filers reported holding INTERSECT ENT INC in Q4 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $358,000 | -85.6% | 21,066 | -76.1% | 0.03% | -84.0% |
| Q4 2018 | $2,483,000 | -24.9% | 88,102 | -0.3% | 0.19% | -18.8% |
| Q2 2018 | $3,308,000 | +10.5% | 88,323 | +16.0% | 0.24% | +6.2% |
| Q1 2018 | $2,993,000 | -45.2% | 76,165 | -54.9% | 0.22% | -43.9% |
| Q4 2017 | $5,466,000 | -21.8% | 168,706 | -24.8% | 0.40% | -15.8% |
| Q3 2017 | $6,992,000 | -1.6% | 224,482 | -11.7% | 0.48% | -8.1% |
| Q2 2017 | $7,109,000 | – | 254,348 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |